Back to search

France· FR:61168571

QUINAPRIL BIOGARAN 20 mg, comprimé pelliculé sécable

A quinapril product containing chlorhydrate de quinapril, registered in France by BIOGARAN, on the national reimbursement list. The same ATC class is registered in 10 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC C09AA06

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedQUINAPRIL BIOGARAN 20 mg, comprimé pe…ATCC09AA06REGISTER NO.FR:61168571PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Quinapril is registered in 10 of 19 countries.

Countries holding a registration under ATC C09AA06 (quinapril), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 7 of them publish a price we can compare per daily dose

Quinapril · ATC C09AA06

10 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Franceprice
  • Italyprice
  • Netherlands
  • Polandprice
  • Spainprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of quinapril costs, country by country.

Normalised to the WHO defined daily dose (15 mg), so markets compare like for like.

  • France: $0.10 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Quinapril · price per daily dose (15 mg)

USD · FX 28 Sept 2026

  • ES Spain$0.14
  • IT Italy$0.13
  • FR France$0.10
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CHLORHYDRATE DE QUINAPRIL
Manufacturer
BIOGARAN
Country
France (FR)
ATC code
C09AA06
ATC class
Quinapril
Defined daily dose
15 mg, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400937800334
    plaquette(s) aluminium polyamide PVC de 28 comprimé(s)
    EUR 3.42

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

407 interactions on record for quinapril.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Quinapril · interactions on record

407 records

  • 11 severe
  • 190 moderate
  • 17 minor
  • 114 info

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium gluconateA12BA05severe
  • Potassium chlorideB05XA01severe

75 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Quinapril in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All quinapril products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Belgium · Quinapril Eg
  • Spain · Lidaltrin, Quinapril Normon
  • Italy · Quinapril Eg, Quinazil
  • Netherlands · Quinapril Cf
  • Poland · Acurenal, Pulsaren

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8d8dab5c-0715-4a6f-9842-f04a2a8be6e5
GET /v1/drugs/8d8dab5c-0715-4a6f-9842-f04a2a8be6e5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "61168571",
  "date_amm": "2006-12-18",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "CHLORHYDRATE DE QUINAPRIL",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": "Warning disponibilité",
  "forme_pharmaceutique": "comprimé pelliculé sécable",
  "voies_administration": "orale",
  "etat_commercialisation": "Non commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about quinapril.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.